PICODAN 12 G
CITRIC ACID : 12 G SODIUM PICOSULFATE : 10 MG MAGNESIUM OXIDE : 3.5 G · DIN 02300583 · ODAN LABORATORIES LTD
Health Canada status: CANCELLED POST MARKET
What is PICODAN?
PICODAN 12 G contains CITRIC ACID : 12 G SODIUM PICOSULFATE : 10 MG MAGNESIUM OXIDE : 3.5 G. It is listed in the Health Canada Drug Product Database under DIN 02300583, held by ODAN LABORATORIES LTD, supplied as POWDER FOR SOLUTION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Dec-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02300583 |
|---|---|
| Brand name | PICODAN |
| Generic / active ingredient | CITRIC ACID : 12 G SODIUM PICOSULFATE : 10 MG MAGNESIUM OXIDE : 3.5 G |
| Manufacturer | ODAN LABORATORIES LTD |
| Strength | 12 G |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | ORAL |
| Schedule | Ethical |
| ATC code | A06AB58 SODIUM PICOSULFATE, COMBINATIONS |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-Dec-2012 |
| Original market date | 2007-10-17 00:00:00 |
Is SODIUM PICOSULFATE, COMBINATIONS in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code A06AB58 SODIUM PICOSULFATE, COMBINATIONS. 2 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PICO-SALAX | 10 MG | POWDER FOR SOLUTION | FERRING INC | MARKETED | DIN 02254794 |
| PURG-ODAN | 12 G | POWDER FOR SOLUTION | ODAN LABORATORIES LTD | MARKETED | DIN 02317966 |
| CITRACLEEN | 10 MG / 15.08 G | POWDER FOR SOLUTION | LABORATORIOS CASEN-FLEET, S.L.U. | APPROVED | DIN 02437880 |
| ORAL PURGATIVE | 3.5 G | POWDER FOR SOLUTION | ODAN LABORATORIES LTD | CANCELLED POST MARKET | DIN 02370271 |
| PICOFLO | 10 MG | POWDER FOR SOLUTION | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02358298 |
Who else supplies SODIUM PICOSULFATE, COMBINATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SODIUM PICOSULFATE, COMBINATIONS appears in 5432 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.